Showing 682 news articles about Starting treatment

Filters Content type: News Topic: Starting treatment

Everyone who has diagnosed HIV is recommended to take HIV treatment. It is better for your health to begin HIV treatment sooner, rather than later.

Starting treatment

Atazanavir: final phase III results published

News
2 August 2004
Starting treatment

Initiating HAART with any one of four 3 x 5 drug choices leads to longest survival in San Francisco

News
13 July 2004
Treatment simplification strategies

Could monotherapy with Kaletra become an option for HIV treatment?

News
13 July 2004
Starting treatment

Tenofovir has viral potency, a good lipid and safety profile, and should be available for first line HAART says study

News
12 July 2004
Starting treatment

Starting HAART soon after HIV infection leads to greater reduction in viral reservoir

News
30 June 2004
Starting treatment

EuroSIDA: patients with higher baseline CD4 have higher risk of immunologic failure on HAART

News
24 June 2004
Starting treatment

Early treatment with a four-drug combination a good option for HIV-infected infants

News
11 June 2004
Starting treatment

Delaying HAART until CD4 counts are below 200 cells/mm3 results in poorer outcome

News
26 May 2004
Starting treatment

Symptoms just as good as CD4 counts for identifying who needs treatment in South Africa

News
21 May 2004
CD4 count

Symptoms versus laboratory monitoring as criteria for starting treatment

News
20 May 2004
Starting treatment

Limited role in care for total lymphocyte count?

News
20 May 2004
Resistance

Offer baseline resistance tests to newly diagnosed UK immigrants, warn Brighton clinicians

News
14 May 2004
Starting treatment

Prednisolone delays CD4 T-cell decreases in chronic HIV infection

News
7 May 2004
Starting treatment

Slow clearance of virus after primary infection is strongest predictor of progression to AIDS

News
5 May 2004
Starting treatment

Four year follow-up shows Kaletra to be safe, effective, durable

News
5 April 2004
Starting treatment

US treatment guidelines updated

News
25 March 2004
Starting treatment

Fixed-dose ARV combinations: choices and challenges

News
19 March 2004
Starting treatment

Adherence, not baseline CD4 cell count, linked to CD4 cell gain on HAART

News
25 February 2004
Starting treatment

Genetic analysis suggests control of inflammation could help some delay HIV treatment

News
23 February 2004
Starting treatment

NNRTI-based HAART effective and safe for primary HIV infection

News
13 February 2004
PEP

PEP for sexual exposure to HIV not 100% effective

News
10 February 2004
Starting treatment

HAART clinically and immunologically effective in babies but high rate of virologic failure

News
9 February 2004
PEP

Nevirapine should not be used for PEP confirms US review

News
2 February 2004
Starting treatment

Meta-analysis finds PI-based HAART better than NNRTI regimens in NRTI experienced

News
30 January 2004
This block is broken or missing. You may be missing content or you might need to enable the original module.